Literature DB >> 28841508

Adding motor control training to muscle strengthening did not substantially improve the effects on clinical or kinematic outcomes in women with patellofemoral pain: A randomised controlled trial.

Nayra Deise Dos Anjos Rabelo1, Leonardo Oliveira Pena Costa2, Bruna Maria de Lima3, Amir Curcio Dos Reis4, André Serra Bley5, Thiago Yukio Fukuda6, Paulo Roberto Garcia Lucareli7.   

Abstract

DESIGN: Randomized controlled trial.
BACKGROUND: Patients with Patellofemoral pain (PFP) usually present muscular weakness, pain and impaired motor control. Muscle strengthening is an effective treatment strategy for PFP, but the additional benefits of movement control training remain unknown. Therefore, the aim of this study was to compare the effects of movement control training associated with muscle strengthening, with a conventional program of strengthening alone in women with PFP.
METHODS: Thirty-four women were randomly assigned to two groups. The Strengthening group (S group) performed 12 sessions to strengthen the knee and hip muscles. The Movement Control & Strengthening group (MC&S group) performed the same exercises and movement control training of the trunk and lower limbs. Effects of the treatment (i.e., between-group differences) were calculated using linear mixed models. Primary outcomes were function and pain intensity after completion of the treatment protocol. Secondary outcomes were; muscle strength and kinematic outcomes during the step down task after 4 weeks of treatment; and function and pain intensity 3 and 6 months after randomization.
RESULTS: The MC&S group did not present significantly better function (MD -2.5 points, 95% CI;-10.7-5.5) or pain (MD -0.3 points, 95% CI;-1.7-1.0) at 4 weeks. There was a small difference in favour of the MC&S group for AKPS scores at 3 months (MD -8.5 points; 95% CI;-16.8 to -0.3). No significant between-group differences were observed for the other outcomes.
CONCLUSION: Movement control training was no more effective than the isolated strengthening protocol, in terms of pain, function, muscle strength, or kinematics.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anterior knee pain; Hip; Kinematics; Motor control; Patella

Mesh:

Year:  2017        PMID: 28841508     DOI: 10.1016/j.gaitpost.2017.08.018

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  5 in total

1.  Response the letter to the editor for the masterclass: Do hip muscle weakness and dynamic knee valgus matter for the clinical evaluation and decision-making process in patients with patellofemoral pain?

Authors:  Nayra Deise Dos Anjos Rabelo; Paulo Roberto Garcia Lucareli
Journal:  Braz J Phys Ther       Date:  2018-05-24       Impact factor: 3.377

2.  Letter to editor in chief: Do hip muscle weakness and dynamic knee valgus matter for the clinical evaluation and decision making process in patients with patellofemoral pain?

Authors:  João Barboza da Silva Neto; Thiago Yukio Fukuda
Journal:  Braz J Phys Ther       Date:  2018-05-18       Impact factor: 3.377

3.  Effects of neuromuscular training and strengthening of trunk and lower limbs muscles in women with Patellofemoral Pain: A protocol of randomized controlled clinical trial, blinded.

Authors:  Natália Camin Silva; Matheus de Castro Silva; Morisa Garcia Guimarães; Manoela Beatriz de Oliveira Nascimento; Lilian Ramiro Felicio
Journal:  Trials       Date:  2019-10-11       Impact factor: 2.279

Review 4.  Trunk, Hip and Knee Exercise Programs for Pain Relief, Functional Performance and Muscle Strength in Patellofemoral Pain: Systematic Review and Meta-Analysis.

Authors:  Denisa Manojlović; Žiga Kozinc; Nejc Šarabon
Journal:  J Pain Res       Date:  2021-05-26       Impact factor: 3.133

Review 5.  Do hip muscle weakness and dynamic knee valgus matter for the clinical evaluation and decision-making process in patients with patellofemoral pain?

Authors:  Nayra Deise Dos Anjos Rabelo; Paulo Roberto Garcia Lucareli
Journal:  Braz J Phys Ther       Date:  2017-11-08       Impact factor: 3.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.